151 related articles for article (PubMed ID: 38643217)
1. Specific mortality in patients with diffuse large B-cell lymphoma: a retrospective analysis based on the surveillance, epidemiology, and end results database.
Xu H; Yan R; Ye C; Li J; Ji G
Eur J Med Res; 2024 Apr; 29(1):241. PubMed ID: 38643217
[TBL] [Abstract][Full Text] [Related]
2. Benefits of Dynamic Nomogram Models for Elderly Diffuse Large B-Cell Lymphoma Patients' Early Death Prediction and Clinical Application.
Zhang L; Jing H; Tang S; Wang J; Yang P
Mediators Inflamm; 2023; 2023():7874239. PubMed ID: 37096156
[TBL] [Abstract][Full Text] [Related]
3. Predictive Modelling of Overall Survival in Adult Patients with Primary Diffuse Large B-cell Lymphoma of the Breast Using the Surveillance, Epidemiology, and End Results (SEER) Database.
Liu Y; Han H; Wei H; Wang X; Luan Z; Jiang K
Recent Pat Anticancer Drug Discov; 2024; 19(3):373-382. PubMed ID: 37464821
[TBL] [Abstract][Full Text] [Related]
4. What factors are associated with the prognosis of primary testicular diffuse large B-cell lymphoma? A study based on the SEER database.
Yang S; Chang W; Zhang B; Shang P
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10269-10278. PubMed ID: 37270733
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of nomogram prognostic model for predicting OS in patients with diffuse large B-cell lymphoma: a cohort study in China.
Li X; Xu Q; Gao C; Yang Z; Li J; Sun A; Wang Y; Lei H
Ann Hematol; 2023 Dec; 102(12):3465-3475. PubMed ID: 37615680
[TBL] [Abstract][Full Text] [Related]
6. [Based on CT radiomics model for predicting the response to first-line chemotherapy of diffuse large B-cell lymphoma].
Yin MX; Su QN; Song X; Zhang JX
Zhonghua Zhong Liu Za Zhi; 2023 May; 45(5):438-444. PubMed ID: 37188630
[No Abstract] [Full Text] [Related]
7. Development and validation of a survival nomogram in patients with primary testicular diffuse large B-cell lymphoma.
Zhi Y; Bao S; Mao J; Chai G; Liu C; Zhu J
J Int Med Res; 2023 Sep; 51(9):3000605231197052. PubMed ID: 37676929
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a nomogram for predicting cardiovascular mortality risk for diffuse large B-cell lymphoma in children, adolescents, and adults.
Mu K; Zhang J; Gu Y; Huang G
Front Pediatr; 2024; 12():1346006. PubMed ID: 38384660
[TBL] [Abstract][Full Text] [Related]
9. Nomogram for Predicting the Overall Survival of Adult Patients With Primary Gastrointestinal Diffuse Large B Cell Lymphoma: A SEER- Based Study.
Wang J; Zhou M; Zhou R; Xu J; Chen B
Front Oncol; 2020; 10():1093. PubMed ID: 32719748
[No Abstract] [Full Text] [Related]
10. Prediction of death probability in adenocarcinoma of the transverse colon: competing-risk nomograms based on 21,469 patients.
Su H; Wang S; Xie S; Huang L; Pan Y; Lyu J
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10435-10452. PubMed ID: 37278827
[TBL] [Abstract][Full Text] [Related]
11. Construction of web
Zhan G; Cao P; Peng H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 48(10):1546-1560. PubMed ID: 38432884
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a [
Li M; Yao H; Zhang P; Zhang L; Liu W; Jiang Z; Li W; Zhao S; Wang K
Eur Radiol; 2023 May; 33(5):3354-3365. PubMed ID: 36547676
[TBL] [Abstract][Full Text] [Related]
13. An Externally Validated Nomogram for Predicting the Overall Survival of Patients With Diffuse Large B-Cell Lymphoma Based on Clinical Characteristics and Systemic Inflammatory Markers.
Liu Y; Sheng L; Hua H; Zhou J; Zhao Y; Wang B
Technol Cancer Res Treat; 2023; 22():15330338231180785. PubMed ID: 37551117
[No Abstract] [Full Text] [Related]
14. Development and Validation of a Novel Risk Stratification Model for Cancer-Specific Survival in Diffuse Large B-Cell Lymphoma.
Zhong Q; Shi Y
Front Oncol; 2020; 10():582567. PubMed ID: 33520698
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of prognostic nomograms for early-onset colon cancer in different tumor locations: a population-based study.
Zhu S; Tu J; Pei W; Zheng Z; Bi J; Feng Q
BMC Gastroenterol; 2023 Oct; 23(1):362. PubMed ID: 37865754
[TBL] [Abstract][Full Text] [Related]
16. Surgery shows survival benefit in patients with primary intestinal diffuse large B-cell lymphoma: A population-based study.
Wang M; Ma S; Shi W; Zhang Y; Luo S; Hu Y
Cancer Med; 2021 May; 10(10):3474-3485. PubMed ID: 33931950
[TBL] [Abstract][Full Text] [Related]
17. A novel NET-related gene signature for predicting DLBCL prognosis.
Shi H; Pan Y; Xiang G; Wang M; Huang Y; He L; Wang J; Fang Q; Li L; Liu Z
J Transl Med; 2023 Sep; 21(1):630. PubMed ID: 37716978
[TBL] [Abstract][Full Text] [Related]
18. Conditional survival analysis and real-time prognosis prediction in stage III T3-T4 colon cancer patients after surgical resection: a SEER database analysis.
Zeng H; Xue X; Chen D; Zheng B; Liang B; Que Z; Xu D; Wang X; Lin S
Int J Colorectal Dis; 2024 Apr; 39(1):54. PubMed ID: 38639915
[TBL] [Abstract][Full Text] [Related]
19. Nomogram-Based Prediction of Overall and Cancer-Specific Survival in Patients with Primary Bone Diffuse Large B-Cell Lymphoma: A Population-Based Study.
Yang XY; He X; Zhao Y
Evid Based Complement Alternat Med; 2022; 2022():1566441. PubMed ID: 35571733
[TBL] [Abstract][Full Text] [Related]
20. Establishment of Prognosis Nomogram for Primary Splenic Diffuse Large B Cell Lymphoma: A Study Based on SEER Database.
Yonghao O; Yongyang W; Siqing Y; Chengchao F; Lihua C; Xin L; Shuju T
Indian J Hematol Blood Transfus; 2024 Apr; 40(2):220-230. PubMed ID: 38708154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
